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Postoperative Infections after Spinal Procedures
Nikolaos Syrmos, Vasilios Valadakis, Konstantinos Grigoriou,
Evangellia Grisbolaki, Dimitrios Arvanitakis. Neurosurgical
Department, Venizeleio General Hospital, Heraklion, Crete,
Greece
Introduction: The rate of postoperative infections following spinal
procedures varies widely depending most of the times in factors
such as- the nature of the procedure, the patient' s diagnosis, the
preoperative comorbidities and other risk factors. A retrospective
case control analysis of 28 cases of postoperative infection follow-
ing spinal procedures was performed.
Material and Methods: A review of 200 spinal procedures revealed
that a postoperative infection developed in 28 patients (14%).
Preoperative risk factors reviewed included smoking and alcohol
abuse, diabetes, previous spinal surgery, previous infections and
body mass index. Intraoperative factors reviewed included the type
of procedures, the operating time and the use of instrumenta-
tion.
Results: The majority of infections (20 cases-71.4%) occurred dur-
ing the early postoperative period (< 6 months). Factors such as-
age of >65 years, smoking and alcohol abuse, diabetes, previous
surgical infection and increased body mass index were statistically
significant preoperative risk factors. The most common organism
cultured from the wounds was Staphylococcus aureus. All patients
were treated with surgical irrigation and débridement, and appro-
priate antibiotics to treat the cultured organism.
Conclusions: It may be appropriate to increase the duration of
prophylactic antibiotics or implement other measures to decrease
the incidence of infection for high risk patients. Whereas extended
prophylactics should be considered in posterior instrumentation,
especially when risk factors are apparent.
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Fungal Infections in Patients Hospitalized in Intensive
Medical Care Unit
Ewa Swoboda-Kopec1, Ewa Stelmach1, Beata Sulik-Tyszka1,
Irena Netsvyetayeva1, Dariusz Kawecki1, Magdalena Sikora1,
Sylwia Blachnio1, Andrzej Kanski2, Miroslaw Luczak1. 1Dept. of
Medical Microbiology Medical University of Warsaw, Poland;
2Dept. of Anaesthesiology and Intensive Care Medical University
of Warsaw, Poland
Introduction: Fungal infections in patients hospitalized in Intensive
Medical Care Unit are a serious clinical problem. Candida genus is
the leading fungal pathogen in intensive care units.
Objective: In our study we analyzed the occurrence of fungal
strains and their susceptibility to antifungal agents in samples of
clinical material taken from patients hospitalized in Intensive Med-
ical Care Unit of Central Clinical Hospital in Warsaw in 2007.
Material and Methods: In total 1697 samples of clinical materials
from hospitalized patients were tested in Microbiological Labora-
tory. From Intensive Care Unit the most common clinical speci-
mens were taken from respiratory tract 22 (30%), digestive tract
(stool) 15 (21%), urine samples 14 (19%), blood 13 (18%), wound
swabs 5 (7%) and other 4 (5%). Specimens were cultured on Sabo-
raud medium plates supplemented with gentamicine and chloram-
phenicol (Becton Dickinson). Isolated strains were identified using
CHROMagar Candida agar and automatic test ID32 C (bioMerieux).
Susceptibility tests were done with E-tests (AB Biodisck) for Am-
photericin B, Fluconazole, Itraconazole and Voriconazole.
Results: In total number of 1697 microbiological examination, 73
samples (4.3%) were positive. We cultured 88 of fungal strains. 86
(97.7%) of them were yeast like fungi and 2 were moulds (2.3%).
Yeast like fungi isolated from clinical materials belonged to ten
species: C. albicans 41 (47.6%), C. glabrata 16 (18.6%), C. tropicalis
11 (12.8%) and C. parapsilosis 9 (10.5%), other 9 (10.5%). The iso-
lated moulds 2 strains (2.3%) were Aspergillus niger and Aspergillus
fumigatus. We cultured n=31 (35%) fungal strains from respiratory
tract samples and n=14 strains (16%) from blood. The major eti-
ological factors of fungemia in our study were: C. parapsilosis 5
strains, C.albicans 4, C. tropicalis 4. All fungal strains were sen-
sitive to Amphotericin B and Voriconazole, 30% of the C. glabrata
were resistant to Itraconazole. C. albicans strains were sensitive
to Fluconazole. The moulds were sensitive to Amphotericin B and
Voriconazole (100%).
Conclusions: C. albicans species was dominated pathogen cultured
from Department of Medical Intensive Care Unit. C. glabrata was
resistant to Itraconazole in 30%. Amphotericin B and Voriconazole
were the most active in vitro antifungal agents against isolated
fungal strains.
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Risk Factors for Bloodstream Infections due to
Multidrug-resistant Gram-negative Non-fermenting
Bacteria in a Burn Unit
Süheyla Senger1, Funda Timurkaynak1, Hande Arslan1,
Turhan Togan1, Özgür Bas¸aran2, Mehmet Haberal2. 1Department
of Infectious Disease, Baskent University dept of clinical
microbiology and infectious disease Ankara, Turkey; 2General
Surgery, Baskent University dept of clinical microbiology and
infectious disease Ankara, Turkey
Objectives: Gram-negative non-fermenting bacteria are a major
cause of nosocomial infections, and their antibiotic resistance
is an important problem. We evaluated risk factors for blood-
stream infections due to multidrug-resistant, Gram-negative, non-
fermenting bacteria among burn patients.
Methods: This retrospective chart-review study was done at
the burn unit of Baskent University Ankara Hospital in Ankara,
Turkey. Because risk factors for bloodstream infections are due to
multidrug-resistant non-fermenting bacteria, we considered age,
sex, length of hospital stay before a diagnosis of bloodstream in-
fections was made, prior exposure to antibiotics, total burned sur-
face area, ventilatory support, presence of a tracheostomy, and
whether the bloodstream infections was primary or secondary. An-
tibiotic susceptibility testing was done by the Kirby-Bauer method
according to Clinical and Laboratory Standards Institute criteria.
Table 1. Risk factors for multidrug-resistant, Gram-negative,
non-fermenting bacteria and their relation to bloodstream infections
Variable Multidrug-resistant Control P Value
Group Group
(n=10) (n=10)
Mean age (years) 20.9 35.0 0.08
Male sex 9 7 0.26
TBSA* (mean, %) 41.1 46.5 0.71
Length of stay prior to BSI** 28.7 19.0 0.16
Ventilatory support 8 7 0.60
Presence of a tracheostomy 5 4 0.65
Primary BSI 2 7 0.07
Secondary BSI 8 3 0.07
Prior exposure to antibiotics 10 9 0.30
Carbapenems 4 0 0.09
Piperacillin/tazobactam 6 5 0.65
Aminoglycosides 8 0 0.001
Quinolones 3 1 0.26
1st generation cephalosporins 6 3 0.17
3rd generation cephalosporins 9 10 0.30
4th generation cephalosporin 3 1 0.26
Glycopeptides 8 7 0.60
*TBSA: Total body surface area, **BSI: bloodstream infections.
